Glutamate and Antipsychotic Treatment Response in Patients with Schizophrenia: a Cross-Sectional Multimodal MRI Study

Glutamate and Antipsychotic Treatment Response in Patients with Schizophrenia: a Cross-Sectional Multimodal MRI Study - Glutamate and Antipsychotic Treatment Response in Patients with Schizophrenia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024392

Enrollment

Registered

2016-10-17

Start date

2016-10-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Magnetic Resonance Imaging (45 minutes) -T1 (5) -Proton Magnetic Resonance Spectroscopy (10) -Diffusion Tensor Imaging (15) -Resting-state functional Magnetic Resonance Imaging (15) Electroence

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Not translated yet

Exclusion criteria

Exclusion criteria: Not translated yet

Design outcomes

Primary

Measure	Time frame
Not translated yet	—

Secondary

Measure	Time frame
Not translated yet	—

Countries

Japan

Contacts

Public ContactNakajima Shinichiro

Keio University School of Medicine Department of Neuropsychiatry

shinichiro_nakajima@hotmail.com03-3353-1211(61857)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026